Home Cart Sign in  
Chemical Structure| 492-08-0 Chemical Structure| 492-08-0

Structure of (+)-Sparteine
CAS No.: 492-08-0

Chemical Structure| 492-08-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(+)-Sparteine is a naturally occurring alkaloid that acts as a ganglionic blocker, competitively inhibiting the activity of nicotinic acetylcholine receptors (nAChRs). This compound modulates neurotransmission by blocking nAChRs in the nervous system and holds potential therapeutic applications, particularly in the treatment of hypertension and other disorders related to ganglionic dysfunction.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (+)-Sparteine

CAS No. :492-08-0
Formula : C15H26N2
M.W : 234.38
SMILES Code : [H][C@]1(C2)[C@](CCCC3)([H])N3C[C@]2([H])[C@@](CCCC4)([H])N4C1
MDL No. :MFCD00869353
InChI Key :SLRCCWJSBJZJBV-TUVASFSCSA-N
Pubchem ID :7014

Safety of (+)-Sparteine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P337+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Neocallimastix frontalis RE1 5 or 10 mM 48 h reduced glucose disappearance Appl Environ Microbiol. 1996 Dec;62(12):4666-8
HIT-T15 cells 171 μM To investigate the inhibitory effect of sparteine on ATP-regulated K currents in HIT-T15 cells, results showed that sparteine reversibly inhibited both whole-cell K-ATP currents and single channel currents. Br J Pharmacol. 1991 Nov;104(3):579-84
Human Peripheral Blood Mononuclear Cells (PBMCs) 5 μM 5 days To evaluate the effect of Sparteine Sulfate on the expression of FoxP3, TGF-β, and IL-10 mRNA in PBMCs. Results showed that Sparteine Sulfate increased the expression of FoxP3, TGF-β, and IL-10 mRNA. Biology (Basel). 2020 Aug 6;9(8):211

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.27mL

0.85mL

0.43mL

21.33mL

4.27mL

2.13mL

42.67mL

8.53mL

4.27mL

References

 

Historical Records

Categories